Consistent with the clinical finding, ILP‐TNF/Mel had little effect on tumour growth at the challenge site in comparison to an untreated control (median 14 vs. 12 days, P = 0.3173, log‐rank test) (Figs 6D and E, and EV6A and B). The gene discussed is TNF; the disease is neoplasm.